Phan T D, D'Souza B, Rattray M J, Johnston M J, Cowie B S
Department of Anaesthesia, University of Melbourne and St Vincent's Hospital, Melbourne, Victoria.
Department of Colorectal Surgery, St Vincent's Hospital, Fitzroy, Victoria.
Anaesth Intensive Care. 2014 Nov;42(6):752-60. doi: 10.1177/0310057X1404200611.
There is continued controversy regarding the benefits of goal-directed fluid therapy, with earlier studies showing marked improvement in morbidity and length-of-stay that have not been replicated more recently. The aim of this study was to compare patient outcomes in elective colorectal surgery patients having goal-directed versus restrictive fluid therapy. Inclusion criteria included suitability for an Enhanced Recovery After Surgery care pathway and patients with an American Society of Anesthesiologists Physical Status score of 1 to 3. Patients were intraoperatively randomised to either restrictive or Doppler-guided goal-directed fluid therapy. The primary outcome was length-of-stay; secondary outcomes included complication rate, change in haemodynamic variables and fluid volumes. Compared to restrictive therapy, goal-directed therapy resulted in a greater volume of intraoperative fluid, 2115 (interquartile range 1350 to 2560) ml versus 1500 (1200 to 2000) ml, P=0.008, and was associated with an increase in Doppler-derived stroke volume index from beginning to end of surgery, 43.7 (16.3) to 54.2 (21.1) ml/m(2), P <0.001, in the latter group. Length-of-stay was similar, 6.5 (5 to 9) versus 6 (4 to 9) days, P=0.421. The number of patients with any complication (minor or major) was similar; 0% (30) versus 52% (26), P=0.42, or major complications, 1 (2%) versus 4 (8%), P=0.36, respectively. The increased perioperative fluid volumes and increased stroke volumes at the end of surgery in patients receiving goal-directed therapy did not translate to a significant difference in length-of-stay and we did not observe a difference in the number of patients experiencing minor or major complications.
关于目标导向液体治疗的益处一直存在争议,早期研究显示其在发病率和住院时间方面有显著改善,但近期并未得到重复验证。本研究的目的是比较接受目标导向液体治疗与限制性液体治疗的择期结直肠手术患者的预后。纳入标准包括适合术后加速康复护理路径以及美国麻醉医师协会身体状况评分为1至3分的患者。患者在术中被随机分配至限制性或多普勒引导的目标导向液体治疗组。主要结局是住院时间;次要结局包括并发症发生率、血流动力学变量变化和液体量。与限制性治疗相比,目标导向治疗导致术中液体量更多,分别为2115(四分位间距1350至2560)ml和1500(1200至2000)ml,P = 0.008,并且在后者组中,从手术开始到结束,多普勒衍生的每搏量指数增加,从43.7(16.3)增至54.2(21.1)ml/m²,P <0.001。住院时间相似,分别为6.5(5至9)天和6(4至9)天,P = 0.421。发生任何并发症(轻微或严重)的患者数量相似;分别为0%(30例)和52%(26例),P = 0.42,或严重并发症分别为1例(2%)和4例(8%),P = 0.36。接受目标导向治疗的患者围手术期液体量增加以及手术结束时每搏量增加并未转化为住院时间的显著差异,并且我们未观察到发生轻微或严重并发症的患者数量存在差异。